CRISPR therapy for rare blood disease delivers “life-changing” results
Targeting a pair of rare genetic blood diseases, the experimental therapy has so far been 100 percent effective in all 22 patients treated.
This archive covers milestones and breakthroughs from the scientific and academic world — researchers, universities, and institutions whose work advances human knowledge. Stories here highlight discoveries, studies, and scholarly efforts that point toward a better future.
Targeting a pair of rare genetic blood diseases, the experimental therapy has so far been 100 percent effective in all 22 patients treated.
For years now, Tesla has been working with third-party recyclers to recover materials from their end-of-life battery packs. But the automaker has also been working on its own “unique battery recycling system.“
The new study, led by Dr. Sagar Sengupta from the National Institute of Immunology has however found a novel way to identify the disease as early as stage 1 through his lab’s work on microRNAs
UKRI developed the new policy because “publicly funded research should be available for public use by the taxpayer,” says Duncan Wingham, the funder’s executive champion for open research.
The report, appearing in The Journal of the National Cancer Institute, reflects good news for 11 of the 19 most common cancers among men, and for 14 of the 20 most common cancers among women.
More than one percent of Iceland’s working population participated in the pilot scheme, which cut the usual 40-hour working week to 35-36 hours with no reduction in overall pay, reports The Independent.
The Shusha Island Coral Park will cover 100 hectares and become a global center to showcase innovations to protect and restore coral reefs and accelerate conservation solutions.
Psilocybin performed about as well as the SSRI escitalopram as a treatment for moderate-to-severe major depressive disorder, according to a new double-blinded, randomized experiment.
Each year, nearly a million children develop TB and 205,000 die of TB-related causes. More than 80% of childhood TB deaths occur in those under the age of 5.
In a recently study published in Nature Communications, researchers from France’s Institut Pasteur describe several successful preclinical tests of this asthma vaccine in mice.